Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,353 | 271 | 51.0% |
| Consulting Fee | $2,820 | 1 | 33.0% |
| Honoraria | $750.00 | 1 | 8.8% |
| Travel and Lodging | $535.11 | 4 | 6.3% |
| Education | $79.30 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $4,066 | 50 | $0 (2024) |
| ViiV Healthcare Company | $1,414 | 98 | $0 (2024) |
| Theratechnologies Inc. | $1,085 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $433.51 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $280.10 | 16 | $0 (2021) |
| ABBVIE INC. | $177.49 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $159.32 | 8 | $0 (2019) |
| Allergan Inc. | $139.62 | 10 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $118.72 | 8 | $0 (2018) |
| GlaxoSmithKline, LLC. | $105.51 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $396.16 | 27 | ViiV Healthcare Company ($234.89) |
| 2023 | $266.81 | 17 | ViiV Healthcare Company ($253.76) |
| 2022 | $234.86 | 16 | ViiV Healthcare Company ($176.39) |
| 2021 | $284.21 | 21 | ViiV Healthcare Company ($141.22) |
| 2020 | $99.45 | 7 | ViiV Healthcare Company ($58.46) |
| 2019 | $1,088 | 18 | Theratechnologies Inc. ($925.68) |
| 2018 | $3,886 | 43 | Gilead Sciences, Inc. ($3,550) |
| 2017 | $2,282 | 130 | ViiV Healthcare Company ($385.15) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: HIV | ||||||
| 11/20/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: HIV | ||||||
| 10/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: HIV | ||||||
| 10/23/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: HIV | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.30 | General |
| 10/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| 09/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: HIV | ||||||
| 08/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.87 | General |
| 07/31/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: HIV | ||||||
| 07/23/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: HIV | ||||||
| 07/03/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: HIV | ||||||
| 06/26/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: HIV | ||||||
| 06/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: HIV | ||||||
| 05/29/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Infectious Disease | ||||||
| 05/08/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: HIV | ||||||
| 05/01/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $22.26 | General |
| 04/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: VIROLOGY | ||||||
| 04/03/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: HIV | ||||||
| 04/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: HIV | ||||||
| 03/27/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: VIROLOGY | ||||||
| 03/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: HIV | ||||||
| 03/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.00 | General |
| 03/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: HIV | ||||||
| 02/28/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Infectious Disease | ||||||
| 02/28/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 51 | 99 | $30,029 | $7,709 |
| 2022 | 4 | 71 | 108 | $33,949 | $8,871 |
| 2021 | 3 | 110 | 185 | $60,596 | $16,325 |
| 2020 | 3 | 99 | 176 | $54,943 | $14,261 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 53 | $13,091 | $3,512 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 32 | $8,384 | $2,282 | 27.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $8,554 | $1,914 | 22.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $13,442 | $3,769 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 39 | $10,218 | $2,482 | 24.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 27 | $6,669 | $1,662 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 20 | $3,620 | $958.99 | 26.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 39 | $23,829 | $6,409 | 26.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 47 | 99 | $24,453 | $6,101 | 25.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 47 | $12,314 | $3,815 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 45 | 86 | $21,242 | $5,512 | 25.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 28 | 29 | $17,719 | $5,189 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 61 | $15,982 | $3,560 | 22.3% |
About Dr. Diana Finkel, DO
Dr. Diana Finkel, DO is a Internal Medicine healthcare provider based in Newark, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780704205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diana Finkel, DO has received a total of $8,537 in payments from pharmaceutical and medical device companies, with $396.16 received in 2024. These payments were reported across 279 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,353).
As a Medicare-enrolled provider, Finkel has provided services to 331 Medicare beneficiaries, totaling 568 services with total Medicare billing of $47,166. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Newark, NJ
- Active Since 03/29/2007
- Last Updated 02/22/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780704205
Products in Payments
- Truvada (Drug) $3,469
- TROGARZO (Drug) $990.30
- DOVATO (Drug) $444.79
- CABENUVA (Biological) $334.36
- TRIUMEQ (Drug) $319.11
- PREZCOBIX (Drug) $317.25
- ISENTRESS (Drug) $155.49
- DIFICID (Drug) $127.64
- APRETUDE (Biological) $124.68
- JULUCA (Drug) $112.14
- EGRIFTA (Drug) $94.98
- ANORO (Drug) $85.77
- TOUJEO (Drug) $81.10
- AVYCAZ (Drug) $71.14
- Edarbi (Drug) $69.38
- SEROSTIM (Biological) $68.32
- Mavyret (Drug) $64.25
- FARXIGA (Drug) $61.85
- VIBATIV (Drug) $61.50
- MAVYRET (Drug) $56.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newark
Marc Cohen, Md, MD
Internal Medicine — Payments: $1.2M
Seth Ivins, Md, MD
Internal Medicine — Payments: $459,110
Dr. Helio Pedro, M.d, M.D
Internal Medicine — Payments: $149,601
Tabassum Salam, Md, MD
Internal Medicine — Payments: $74,050
Dr. Jamil Shah, Md, MD
Internal Medicine — Payments: $53,152
Dr. Christina Migliore, M.d, M.D
Internal Medicine — Payments: $33,681